KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Feb 26, 2026 - 3:59PM >>  ABB India 6129.1  [ -0.59% ]  ACC 1619.55  [ -0.24% ]  Ambuja Cements 512.2  [ 0.23% ]  Asian Paints 2395.95  [ -0.82% ]  Axis Bank 1395  [ -0.53% ]  Bajaj Auto 10108.8  [ 0.10% ]  Bank of Baroda 324.5  [ 2.77% ]  Bharti Airtel 1928.5  [ 0.78% ]  Bharat Heavy 264.85  [ 1.17% ]  Bharat Petroleum 385.4  [ 1.15% ]  Britannia Industries 6133  [ -0.30% ]  Cipla 1357.8  [ 0.90% ]  Coal India 433.5  [ -1.13% ]  Colgate Palm 2295.35  [ 1.10% ]  Dabur India 524.3  [ 0.99% ]  DLF 611.8  [ 0.08% ]  Dr. Reddy's Lab. 1315  [ 0.64% ]  GAIL (India) 169.95  [ 0.00% ]  Grasim Industries 2865.6  [ -0.29% ]  HCL Technologies 1373.45  [ -0.25% ]  HDFC Bank 898.85  [ -0.98% ]  Hero MotoCorp 5783.7  [ 0.81% ]  Hindustan Unilever 2380  [ 0.23% ]  Hindalco Industries 941  [ 0.44% ]  ICICI Bank 1404.95  [ 0.35% ]  Indian Hotels Co. 682  [ 0.80% ]  IndusInd Bank 964.45  [ 2.91% ]  Infosys 1289.35  [ -0.08% ]  ITC 318.2  [ -0.44% ]  Jindal Steel 1260.65  [ -0.50% ]  Kotak Mahindra Bank 424.55  [ -0.12% ]  L&T 4285.9  [ -0.32% ]  Lupin 2323.85  [ 1.37% ]  Mahi. & Mahi 3484.05  [ -0.21% ]  Maruti Suzuki India 15214  [ 1.02% ]  MTNL 30.35  [ 3.13% ]  Nestle India 1317.6  [ -0.38% ]  NIIT 72.26  [ 0.56% ]  NMDC 82.59  [ 0.88% ]  NTPC 381.85  [ -0.79% ]  ONGC 280.15  [ 0.99% ]  Punj. NationlBak 130.45  [ -0.04% ]  Power Grid Corpn. 303.5  [ -1.20% ]  Reliance Industries 1408  [ 0.70% ]  SBI 1209.2  [ 0.75% ]  Vedanta 737.35  [ 1.33% ]  Shipping Corpn. 268.15  [ 1.07% ]  Sun Pharmaceutical 1787.5  [ 1.34% ]  Tata Chemicals 715.3  [ -0.49% ]  Tata Consumer Produc 1154.4  [ -1.51% ]  Tata Motors Passenge 391.65  [ 2.54% ]  Tata Steel 215.5  [ 0.40% ]  Tata Power Co. 380.05  [ -0.30% ]  Tata Consult. Serv. 2647.7  [ 0.69% ]  Tech Mahindra 1361.8  [ 0.00% ]  UltraTech Cement 12937  [ -0.81% ]  United Spirits 1386.65  [ -1.78% ]  Wipro 201  [ -0.42% ]  Zee Entertainment 87.42  [ -1.13% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

ARVEE LABORATORIES (INDIA) LTD.

26 February 2026 | 03:31

Industry >> Chemicals - Speciality

Select Another Company

ISIN No INE006Z01016 BSE Code / NSE Code / Book Value (Rs.) 30.19 Face Value 10.00
Bookclosure 24/09/2025 52Week High 291 EPS 1.95 P/E 82.59
Market Cap. 177.30 Cr. 52Week Low 134 P/BV / Div Yield (%) 5.33 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
The Company was incorporated as Arvee Laboratories (India) Private Limited under the provisions of the Companies Act, 1956 vide certificate of incorporation dated January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the name of the company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public company vide shareholder's approval dated September 11, 2017 and vide fresh certificate of incorporation dated September 19, 2017. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2012 - The Company was incorporated as Arvee Laboratories (India) Private Limited. 2013 - Acquired land, building and machineries from Skylink Chemicals Private Limited and started manufacturing unit. - Started construction of its first plant for Thiophene Derivatives. - Completes construction and commissioning of its Thiophene Derivatives Plant. 2014 - Plant inspected and approved by leading India pharmaceutical manufacturer for supply of Thiophene Derivatives. - Started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid. - Received ISO 9001:2008 accreditation for NABCB and DAKKS from TUV NORD. - Plant inspected and approved by an American X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer. - Plant inspected and approved by a European X-Ray Contrast Media manufacturer and started pilot trials with the manufacturer. 2015 - Completed construction and commissioning of plant for Nitro Derivatives of Isophthalic Acid. - After receiving inspection approval, our Company gets order for yearly supply of Nitro Derivatives of Isophthalic Acid to leading contrast media manufacturer in the United States of America. - Export to United States of America (USA) started. - Plant inspected and approved by European manufacturer for supply of Thiophene Derivatives. - Export of Thiophene Derivatives started to Europe. 2016 - Receives internal approvals for our Nitro Derivatives of Isophthalic acid from leading XRay contrast media manufacturer in Europe. - Receive approval for our Sulfo Derivatives of Isophthalic acid from a large polymer manufacturer in the United States of America and received yearly order for supply of Sulfo Derivatives to the USA. - Crossed turnover of Rs. 25 crores. 2017 - Plant inspected and approved by an American X-ray contrast media manufacturer who has the largest market share in the world and started of pilot trials with the manufacturer. - Received order for commercial trials of Nitro Derivatives of Isophthalic acid from the largest manufacturer of X-ray contrast media manufacturer in the world. - The name of our Company was changed to Arvee Laboratories (India) Limited pursuant to conversion into a public limited company. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1.